.svg){kind=small}
Apr-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Missouri market, Amend Cannabis has shown a consistent performance in the Tincture & Sublingual category, maintaining the 4th rank from January to April 2024. This stability is noteworthy, especially considering the fluctuating nature of the cannabis market. The sales in this category have seen a significant rise from January's $19,818 to March's $25,684, before experiencing a dip in April to $13,270. This trend suggests a strong start to the year for Amend Cannabis in this category, indicating a robust demand for their Tincture & Sublingual products among Missouri consumers. However, the decrease in April might signal a need for strategic adjustments to maintain their market position.
On the other hand, the Topical category tells a slightly different story for Amend Cannabis in Missouri. Starting the year at the 5th rank and slipping to the 6th by March and April indicates a slight decline in their competitive stance within this category. Despite this slight drop in rankings, it's important to note that they remained within the top 10, showcasing a continued presence in the market. The sales trajectory, however, mirrored the Tincture & Sublingual category with a peak in January at $36,479, followed by a gradual decline in the subsequent months. This pattern suggests that while Amend Cannabis enjoys a strong market presence, there may be emerging challenges or increased competition affecting their performance in the Topical category.
Competitive Landscape
In the competitive landscape of the topical cannabis market in Missouri, Amend Cannabis has experienced a slight decline in its rank and sales over the first four months of 2024. Initially ranked 5th in January, it slipped to 6th place by March and maintained this position into April, indicating a challenge in sustaining its market position against its competitors. Notably, Heartland Labs has consistently held a higher rank and demonstrated stronger sales performance, maintaining the 4th position throughout the period. Similarly, Vlasic Labs showed resilience and growth, moving from 6th to 5th place by March, with sales figures reflecting a positive trend. On the other hand, Pharma Girl Cannabis World and True State have also been key players, with True State entering the rankings in February and showing a promising increase in sales, despite starting from a lower base. This competitive analysis underscores the dynamic nature of the market and highlights the importance for Amend Cannabis to strategize effectively to regain and enhance its market standing amidst stiff competition.
Notable Products
In April 2024, Amend Cannabis saw the CBD/THC 1:1 Tincture (100mg CBD, 100mg THC, 30ml) maintain its position as the top-selling product, with sales reaching 571 units. Following closely in rank was the CBD/THC 1:1 Amend Infused Balm (50mg CBD, 50mg THC), which also held its second-place position consistently over the past months. The CBD/THC/CBC 1:1:1 Transdermal Lotion (50mg CBD, 50mg THC, 50mg CBC) remained in third place, showing a stable preference among consumers for topicals. The CBD/THC 1:1 Amend Infused Balm (100mg CBD, 100mg THC) saw a slight fluctuation in its ranking earlier in the year but secured the fourth spot in April. Notably, the CBD/THC 1:1 Amend Infused Balm (250mg CBD, 250mg THC) made its debut in the rankings in April, taking the fifth position, indicative of a growing interest in higher potency products.
Top Selling Cannabis Brands
